Press and Media

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine

Metabolomics, an emerging clinical modality, enabling precision, personalized medicine
Read More →

Metabolomics: The Next Step in Precision Medicine

Metabolomics can measure the actual physiological state of an individual, providing new health insights
Read More →

Lifespin Establishes U.S. Corporate Entity in Anticipation of Market Expansion

BOSTON (MA), April 12th, 2022 — Lifespin GmbH, a deep data company that is mapping ...
Read More →

Article about lifespin GmbH in the regional press (Donaukurier)

Das Regensburger Unternehmen Lifespin digitalisiert Stoffwechselproben und wagt heuer den Sprung in die USA - Auch die Harvard University ist bei der Entwicklung beteiligt
Read More →

lifespin GmbH secures €2.5M Bridge Financing

Lifespin GmbH Secures €2.5M Bridge Financing to Further Build its AI-Enabled Metabolomics-Based Differential Diagnosis Panel for Neurological Diseases
Read More →

Article about lifespin GmbH in the clinical laboratory journal

Digitization of health
Read More →

In-depth feature of lifespin on GenomeWeb’s 360DX

Lifespin Using NMR to Develop Metabolomics-Based Diagnostics
Read More →
Scroll to Top